Identifying Methylation Biomarkers for Monitoring Bladder Tumors
- Conditions
- Bladder Cancer
- Registration Number
- NCT00244205
- Lead Sponsor
- Copenhagen University Hospital at Herlev
- Brief Summary
To investigate the methylation status of 4-6 genes in Urine and matching bladder tissue biopsies, in order to find methylation markers for use in a noninvasive test in monitoring patients with bladder tumors.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
- Patients with bladder tumors and patients with benign urinary tract conditions with no clinical suspicion of bladder cancer.
Exclusion Criteria
- Patients with competing urinary and systemic diseases, pregnant and patients under 18 years of age.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Copenhagen University Hospital at Herlev
🇩🇰Herlev, Copenhagen, Denmark